Considerations and Determinants of Discharge Decisions among Prenatal Substance Exposed Infants

Tre D Gissandaner1, Alainna Wen2, Jordan A Gette3

  • 1Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.

Child Maltreatment
|March 14, 2023
PubMed

Insights

Prenatal substance exposure and infant withdrawal risk did not predict discharge placement. However, maternal meth/amphetamine use increased the odds of out-of-home placement for infants.

Area of Science:

  • Neonatal Abstinence Syndrome (NAS) research
  • Pediatric substance exposure
  • Child welfare and placement research

Background:

  • Limited research exists on predictors for discharge placement of infants with prenatal substance exposure.
  • Understanding factors influencing discharge decisions is crucial for infant well-being.

Purpose of the Study:

  • To examine predictors of discharge placement for infants exposed to substances prenatally.
  • To identify associations between prenatal substance exposure, infant intervention, and demographic factors with placement decisions.

Main Methods:

  • Latent class analysis (LCA) to identify infant risk classes.
  • Logistic regressions to assess predictor associations with discharge placement.
  • Utilized a validated medical record data extraction tool.

Main Results:

  • LCA identified two classes: Low Withdrawal Risk and High Withdrawal Risk, neither related to discharge placement.
  • Maternal meth/amphetamine use during pregnancy was significantly associated with increased odds of out-of-home placement.
  • Infant intervention type (pharmacologic vs. non-pharmacologic) did not predict placement outcomes.

Conclusions:

  • Infant withdrawal risk classification alone does not determine discharge placement.
  • Prenatal meth/amphetamine exposure is a key factor associated with higher out-of-home placement rates.
  • Further research is needed to validate these findings and explore clinical utility.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
791
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
365
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
204
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
135